John Niederhuber

John Niederhuber

Chairman bei APTEVO THERAPEUTICS INC.

Vermögen: 605 $ am 31.03.2024

85 Jahre
Commercial Services
Consumer Services
Health Technology

Profil

John E.
Niederhuber
is the founder of Inova Translational Medicine Institute, which was founded in 2010.
He held the title of Chief Executive Officer & Executive Vice President at the institute from 2010 to 2019.
Dr. Niederhuber's current job(s) include Chairman at Aptevo Therapeutics, Inc. since 2016, Director at International Biomedical Research Alliance, Director at Virginia Biotechnology Association since 2016, Director at C-Change, Member of the National Academy of Sciences, Member of the National Academy of Medicine (United States), and Member of the Alpha Omega Alpha Honor Medical Society.
Dr. Niederhuber's former job(s) include President & Chief Executive Officer at Genomics & Bioinformatics Research Institute, Chairman-Surgery Department at Stanford University School of Medicine from 1991 to 1997, Director of the National Cancer Institute and the National Institutes of Health from 2006 to 2010, Independent Director at Emergent BioSolutions, Inc. from 2010 to 2016, Independent Director at Novelos Therapeutics, Inc. from 2011 to 2014, Director at University of Wisconsin Carbone Cancer Center, Director at Cellectar Biosciences, Inc., Director at PierianDx, Inc., Executive Vice President at Inova Health System Services from 2010 to 2019, Professor at the University of Michigan from 1973 to 1987, Member of the CEO Roundtable on Cancer, Inc., Professor at The Johns Hopkins University School of Medicine from 1987 to 1991, Professor at the University of Wisconsin School of Medicine & Public Health from 1997 to 2005, and Member of the Mcardle Laboratory For Cancer Research.
Dr. Niederhuber's education history includes an undergraduate degree from Bethany College (West Virginia) and a graduate degree from The Ohio State University College of Medicine.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
01.03.2024 129 ( 0,02% ) 605 $ 31.03.2024

Aktive Positionen von John Niederhuber

UnternehmenPositionBeginn
APTEVO THERAPEUTICS INC. Chairman 01.04.2022
Director/Board Member -
Corporate Officer/Principal -
Director/Board Member 21.01.2016
C-Change Director/Board Member -
Corporate Officer/Principal -
Corporate Officer/Principal -
Alle aktiven Positionen von John Niederhuber

Ehemalige bekannte Positionen von John Niederhuber

UnternehmenPositionEnde
Chief Executive Officer 01.04.2019
Corporate Officer/Principal 01.04.2019
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von John Niederhuber im Detail an

Ausbildung von John Niederhuber

Bethany College (West Virginia) Undergraduate Degree
The Ohio State University College of Medicine Graduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von John Niederhuber im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

25

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
EMERGENT BIOSOLUTIONS INC.

Health Technology

CELLECTAR BIOSCIENCES, INC.

Health Technology

APTEVO THERAPEUTICS INC.

Health Technology

Private Unternehmen16

Health Services

Miscellaneous

Government

Health Technology

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

C-Change

University of Wisconsin Carbone Cancer Center

Commercial Services

Technology Services

Mcardle Laboratory For Cancer Research

Genomics & Bioinformatics Research Institute

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. John Niederhuber